Loading...

Dimitrios Tzachanis

Title(s)Associate Clinical Professor, Medicine
SchoolHealth Sciences
Phone858-534-2185
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wu PA, Stern RS, Huang V, Liu KX, Chen CA, Tzachanis D, Joyce RM, Davis RB, Ho VT. Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell Transplantation. J Invest Dermatol. 2019 Mar; 139(3):591-599. PMID: 30316899.
      View in: PubMed
    2. Papazisis G, Siafis S, Tzachanis D. Tachyphylaxis to the Sedative Action of Mirtazapine. Am J Case Rep. 2018 Apr 07; 19:410-412. PMID: 29626184.
      View in: PubMed
    3. Nahas MR, Soiffer RJ, Kim HT, Alyea EP, Arnason J, Joyce R, Antin JH, Ho VT, Stroopinsky D, Li S, Levine JD, McMasters M, Jain S, Hamdan A, Tzachanis D, Bryant MP, Logan EK, Bazemore J, Stewart J, Joyce A, Stephenson S, Washington A, Cole L, Pyzer A, Leaf RK, Avigan DE, Rosenblatt J. Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease. Blood. 2018 Jun 21; 131(25):2836-2845. PMID: 29549175.
      View in: PubMed
    4. Siafis S, Tzachanis D, Samara M, Papazisis G. Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects. Curr Neuropharmacol. 2018; 16(8):1210-1223. PMID: 28676017.
      View in: PubMed
    5. Filippiadou M, Kouvelas D, Garyfallos G, Tsakiridis I, Tzachanis D, Spachos D, Papazisis G. Exposure to the drug company marketing in Greece: Interactions and attitudes in a non-regulated environment for medical students. Ann Med Surg (Lond). 2017 Jul; 19:23-28. PMID: 28603612.
      View in: PubMed
    6. Epstein JB, Raber-Durlacher JE, Lill M, Linhares YP, Chang J, Barasch A, Slief RI, Geuke M, Zecha JA, Milstein DM, Tzachanis D. Photobiomodulation therapy in the management of chronic oral graft-versus-host disease. Support Care Cancer. 2017 02; 25(2):357-364. PMID: 27655559.
      View in: PubMed
    7. Epstein JB, Gharapetian S, Rejali AR, Zabner R, Lill M, Tzachanis D. Erratum to: Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir. Support Care Cancer. 2016 Aug; 24(8):3607. PMID: 27278274.
      View in: PubMed
    8. Berenson JR, Cartmell A, Bessudo A, Lyons RM, Harb W, Tzachanis D, Agajanian R, Boccia R, Coleman M, Moss RA, Rifkin RM, Patel P, Dixon S, Ou Y, Anderl J, Aggarwal S, Berdeja JG. CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma. Blood. 2016 06 30; 127(26):3360-8. PMID: 27207788; PMCID: PMC4929927.
    9. Epstein JB, Gharapetian S, Rejali AR, Zabner R, Lill M, Tzachanis D. Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir. Support Care Cancer. 2016 08; 24(8):3603-6. PMID: 27165053.
      View in: PubMed
    10. Tzachanis D, Haider M, Papazisis G. A Case of Subacute Encephalopathy Developing After Treatment With Clofarabine and Methotrexate That Resolved With Corticosteroids. Am J Ther. 2016 May-Jun; 23(3):e937-40. PMID: 24987945.
      View in: PubMed
    11. Epstein JB, Kupferman SB, Zabner R, Rejali A, Hopp ML, Lill M, Tzachanis D. Early diagnosis and successful management of oral mucormycosis in a hematopoietic stem cell transplant recipient: case report and literature review. Support Care Cancer. 2016 08; 24(8):3343-6. PMID: 26971955.
      View in: PubMed
    12. Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R, Ratner L, Reid E, Remick S, Sparano J, Tzachanis D, Wachsman W, Chadburn A. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma. 2016 07; 57(7):1731-4. PMID: 26674561.
      View in: PubMed
    13. Arnason JE, Luptakova K, Rosenblatt J, Tzachanis D, Avigan D, Zwicker JI, Levine J, Kim M, Parker JA, Grant B, Joyce RM. Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant. Acta Haematol. 2015; 133(4):347-53. PMID: 25677780.
      View in: PubMed
    14. Tzachanis D, Dewar R, Luptakova K, Chang JD, Joyce RM. Primary cardiac burkitt lymphoma presenting with abdominal pain. Case Rep Hematol. 2014; 2014:687598. PMID: 25431699; PMCID: PMC4241305.
    15. Tapper EB, Luptakova K, Joyce RM, Tzachanis D. A 78-year-old man with acute myeloid leukemia (AML) and acute renal failure. Am J Case Rep. 2014 Aug 30; 15:364-7. PMID: 25184701; PMCID: PMC4159241.
    16. Papazisis G, Tzachanis D. Pregabalin's abuse potential: a mini review focusing on the pharmacological profile. Int J Clin Pharmacol Ther. 2014 Aug; 52(8):709-16. PMID: 24849194.
      View in: PubMed
    17. Tzachanis D, Hamdan A, Uhlmann EJ, Joyce RM. Successful treatment of refractory Guillain-Barré syndrome with alemtuzumab in a patient with chronic lymphocytic leukemia. Acta Haematol. 2014; 132(2):240-3. PMID: 24853856.
      View in: PubMed
    18. Rosenblatt J, Avivi I, Vasir B, Uhl L, Munshi NC, Katz T, Dey BR, Somaiya P, Mills H, Campigotto F, Weller E, Joyce R, Levine JD, Tzachanis D, Richardson P, Laubach J, Raje N, Boussiotis V, Yuan YE, Bisharat L, Held V, Rowe J, Anderson K, Kufe D, Avigan D. Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients. Clin Cancer Res. 2013 Jul 01; 19(13):3640-8. PMID: 23685836.
      View in: PubMed
    19. Luptakova K, Rosenblatt J, Glotzbecker B, Mills H, Stroopinsky D, Kufe T, Vasir B, Arnason J, Tzachanis D, Zwicker JI, Joyce RM, Levine JD, Anderson KC, Kufe D, Avigan D. Lenalidomide enhances anti-myeloma cellular immunity. Cancer Immunol Immunother. 2013 Jan; 62(1):39-49. PMID: 22733396.
      View in: PubMed
    20. Rosenblatt J, Glotzbecker B, Mills H, Vasir B, Tzachanis D, Levine JD, Joyce RM, Wellenstein K, Keefe W, Schickler M, Rotem-Yehudar R, Kufe D, Avigan D. PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine. J Immunother. 2011 Jun; 34(5):409-18. PMID: 21577144.
      View in: PubMed
    21. Avigan D, Tzachanis D. Cancer vaccines in hematologic malignancies: advances, challenges and therapeutic potential. Expert Rev Vaccines. 2010 May; 9(5):451-4. PMID: 20450317.
      View in: PubMed
    22. Rosenblatt J, Wu Z, Vasir B, Zarwan C, Stone R, Mills H, Friedman T, Konstantinopoulos PA, Spentzos D, Ghebremichael M, Stevenson K, Neuberg D, Levine JD, Joyce R, Tzachanis D, Boussiotis V, Kufe D, Avigan D. Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28. J Immunother. 2010 Feb-Mar; 33(2):155-66. PMID: 20145548.
      View in: PubMed
    23. Rosenblatt J, Bissonnette A, Ahmad R, Wu Z, Vasir B, Stevenson K, Zarwan C, Keefe W, Glotzbecker B, Mills H, Joyce R, Levine JD, Tzachanis D, Boussiotis V, Kufe D, Avigan D. Immunomodulatory effects of vitamin D: implications for GVHD. Bone Marrow Transplant. 2010 Sep; 45(9):1463-8. PMID: 20081878.
      View in: PubMed
    24. Tzachanis D, Boussiotis VA. Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression. Cell Cycle. 2009 Apr 01; 8(7):1019-25. PMID: 19270514; PMCID: PMC2908893.
    25. Mauri D, Tzachanis D, Tsekoura P, Xanthakis I, Tsali L, Roumbkou S, Fountzilas G. Weekly docetaxel regimens and radiation pneumonitis. J Support Oncol. 2008 Jul-Aug; 6(6):265-6. PMID: 18724534.
      View in: PubMed
    26. Papazisis G, Kallaras K, Kaiki-Astara A, Pourzitaki C, Tzachanis D, Dagklis T, Kouvelas D. Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy. Int J Neuropsychopharmacol. 2008 May; 11(3):321-9. PMID: 17897482.
      View in: PubMed
    27. Tzachanis D, Li L, Lafuente EM, Berezovskaya A, Freeman GJ, Boussiotis VA. Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-beta signaling in activated T lymphocytes. Blood. 2007 Apr 01; 109(7):2944-52. PMID: 17164348; PMCID: PMC1852213.
    28. Li L, Greenwald RJ, Lafuente EM, Tzachanis D, Berezovskaya A, Freeman GJ, Sharpe AH, Boussiotis VA. Rap1-GTP is a negative regulator of Th cell function and promotes the generation of CD4+CD103+ regulatory T cells in vivo. J Immunol. 2005 Sep 01; 175(5):3133-9. PMID: 16116203.
      View in: PubMed
    29. Tzachanis D, Lafuente EM, Li L, Boussiotis VA. Intrinsic and extrinsic regulation of T lymphocyte quiescence. Leuk Lymphoma. 2004 Oct; 45(10):1959-67. PMID: 15370239.
      View in: PubMed
    30. Tzachanis D, Appleman LJ, Van Puijenbroek AA, Berezovskaya A, Nadler LM, Boussiotis VA. Differential localization and function of ADP-ribosylation factor-6 in anergic human T cells: a potential marker for their identification. J Immunol. 2003 Aug 15; 171(4):1691-6. PMID: 12902467.
      View in: PubMed
    31. Appleman LJ, Tzachanis D, Grader-Beck T, Van Puijenbroek AA, Boussiotis VA. Induction of immunologic tolerance for allogeneic hematopoietic cell transplantation. Leuk Lymphoma. 2002 Jun; 43(6):1159-67. PMID: 12152983.
      View in: PubMed
    32. Tzachanis D, Berezovskaya A, Nadler LM, Boussiotis VA. Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Blood. 2002 Feb 15; 99(4):1465-73. PMID: 11830501.
      View in: PubMed
    33. Tzachanis D, Freeman GJ, Hirano N, van Puijenbroek AA, Delfs MW, Berezovskaya A, Nadler LM, Boussiotis VA. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol. 2001 Dec; 2(12):1174-82. PMID: 11694881.
      View in: PubMed
    34. Appleman LJ, Tzachanis D, Grader-Beck T, van Puijenbroek AA, Boussiotis VA. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics. J Mol Med (Berl). 2001; 78(12):673-83. PMID: 11434720.
      View in: PubMed